Premium
Seres Therapeutics Inc (MCRB)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Eric D. ShaffDirector | -259,00 | 1,95k | Derivative Exercise and Sale | 7,53 | 12,04k | - |
| 2026-05-15 | Mr. Eric D. ShaffDirector | 463,00 | 0,00 | Derivative Exercise and Retained Stock | - | 12,04k | 4,00% |
| 2026-05-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | -77,00 | 579,81 | Derivative Exercise and Sale | 7,53 | 7,84k | - |
| 2026-05-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | 161,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,84k | 2,10% |
| 2026-05-15 | Ms. Kelly BradyExec. VP & COO | -59,00 | 444,27 | Derivative Exercise and Sale | 7,53 | 8,56k | - |
| 2026-05-15 | Ms. Kelly BradyExec. VP & COO | 121,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,56k | 1,43% |
| 2026-05-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | -79,00 | 594,87 | Derivative Exercise and Sale | 7,53 | 7,95k | - |
| 2026-05-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | 165,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,95k | 2,12% |
| 2026-02-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | 166,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,79k | 2,18% |
| 2026-02-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | -78,00 | 660,66 | Derivative Exercise and Sale | 8,47 | 7,79k | - |
| 2026-02-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | 150,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,68k | 1,99% |
| 2026-02-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | -89,00 | 753,83 | Derivative Exercise and Sale | 8,47 | 7,68k | - |
| 2026-02-15 | Dr. Teresa L. YoungInitié | 156,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,56k | 1,86% |
| 2026-02-15 | Dr. Teresa L. YoungInitié | -75,00 | 635,25 | Derivative Exercise and Sale | 8,47 | 8,56k | - |
| 2026-02-15 | Mr. Eric D. ShaffDirector | 464,00 | 0,00 | Derivative Exercise and Retained Stock | - | 11,58k | 4,18% |
| 2026-02-15 | Mr. Eric D. ShaffDirector | -259,00 | 2,19k | Derivative Exercise and Sale | 8,47 | 11,58k | - |
| 2025-11-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | -1,26k | 21,75k | Derivative Exercise and Sale | 17,30 | 7,53k | - |
| 2025-11-15 | Mr. Eric D. ShaffDirector | 504,00 | 0,00 | Derivative Exercise and Retained Stock | - | 11,11k | 4,75% |
| 2025-11-15 | Mr. Eric D. ShaffDirector | -217,00 | 3,75k | Derivative Exercise and Sale | 17,30 | 11,11k | - |
| 2025-11-15 | Dr. Teresa L. YoungInitié | 3,19k | 0,00 | Derivative Exercise and Retained Stock | - | 8,40k | 61,09% |
| 2025-11-15 | Dr. Teresa L. YoungInitié | -1,04k | 18,03k | Derivative Exercise and Sale | 17,30 | 8,40k | - |
| 2025-11-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | 168,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,62k | 2,25% |
| 2025-11-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | -76,00 | 1,31k | Derivative Exercise and Sale | 17,30 | 7,62k | - |
| 2025-11-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | 2,98k | 0,00 | Derivative Exercise and Retained Stock | - | 7,53k | 65,50% |
| 2025-08-15 | Mr. Eric D. ShaffDirector | 507,00 | 0,00 | Derivative Exercise and Retained Stock | - | 10,61k | 5,02% |
| 2025-08-15 | Mr. Eric D. ShaffDirector | -217,00 | 3,61k | Derivative Exercise and Sale | 16,65 | 10,61k | - |
| 2025-08-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | 168,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,46k | 2,31% |
| 2025-08-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | -76,00 | 1,27k | Derivative Exercise and Sale | 16,65 | 7,46k | - |
| 2025-08-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | 165,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,55k | 3,76% |
| 2025-08-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | -73,00 | 1,22k | Derivative Exercise and Sale | 16,65 | 4,55k | - |
| 2025-08-15 | Dr. Teresa L. YoungInitié | 171,00 | 0,00 | Derivative Exercise and Retained Stock | - | 5,22k | 3,39% |
| 2025-08-15 | Dr. Teresa L. YoungInitié | -59,00 | 982,35 | Derivative Exercise and Sale | 16,65 | 5,22k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
